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Time Trade Off
Abstract
Background Health state valuations obtained from the general
population are used for cost-utility analyses of health-care inter-
ventions. Currently, most studies have focused on valuations of
somatic conditions, to a much lesser extent of mental states, that
is, depression and even less on valuations of depression co-occurring
with somatic conditions.
Objective We tested the feasibility of the time trade-oﬀ (TTO) task
to elicit valuations for depression solitary or co-occurring with a
somatic condition. Moreover, we explored person- and state-
related factors that may aﬀect valuations.
Design During semi-structured interviews, 10 individuals (ﬁve
women, mean age: 36 years) used a TTO task to value vignettes
describing mild and severe depression; and mild depression co-
occurring with moderate and severe states of cancer, diabetes or
heart disease. During valuations, participants were thinking aloud.
Feasibility criteria were successful completion and diﬃculty/
concentration (1–10); logical consistency of values; and comprehen-
sion of the TTO, based on qualitative analysis of think aloud data.
Factors inﬂuencing valuations were generated from think aloud data.
Results Participants reported satisfactory levels of diﬃculty (mean:
1.9) and concentration (mean: 8.3) and assigned consistent values.
Qualitative analysis revealed diﬃculties with imagining: living with
depression for lifetime (n = 4); reaching the age of 80 (n = 6); and
living with a somatic condition and mentally healthy (n = 6).
Person- and state-related factors, for example perceived suscepti-
bility to depression (n = 4), appeared to aﬀect valuations.
Conclusion Quantitative ﬁndings supported feasibility of the valua-
tion protocol, yet qualitative ﬁndings indicated that certain task
aspects should be readdressed. Factors inﬂuencing valuations can
be explored to better understand valuations.
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Patients with a chronic somatic condition
experience elevated levels of depression,
compared to the general population.1,2 Co-
occurring depression with a somatic condition
has been related to a worse health-related qual-
ity of life (HRQoL) and medical outcomes.3–5
As such, depression may impose a great burden
on the patient.
Depression can be assessed by diﬀerent types
of measures; most frequently self-report symp-
tom scales are used. An alternative type of the
assessment of depression includes the use of
health state valuations (else called ‘utility
values’, ‘utilities’): a HRQoL indicator appro-
priate for use in economic evaluations of
health-care interventions (i.e. cost-utility
analyses).6 In valuation methodology, a health
state (i.e. depression) is ﬁrst described based
on a standardized classiﬁcation system which
includes several relevant HRQoL domains and
then assigned a value that represents the pref-
erence for living in this health state, in a scale
from 0, representing a state equivalent to death
(in other words, a very low HRQoL associated
with the health state), to 1, representing a state
equivalent to perfect health. These values can
then be used in cost-utility analyses to calculate
the number of quality-adjusted life years
gained by a health-care intervention, as a
means for resource allocation decision-making.
Valuations can be elicited by either patients
who experience the health state or by the
general population imagining it. Oﬃcial guide-
lines suggest the use of the population per-
spective in cost-utility analyses, as these are the
ones who are paying for the health-care
interventions.7
Previous studies have generated valuations
of depression, both in patients with depression
and in the general population.8–10 Values for
depression have been found to range substan-
tially based on the severity of the depression
state. For example, in a study of Bennett
et al.,8 mild depression, as described based on
the McSad depression speciﬁc classiﬁcation sys-
tem, was valued more or less halfway the score
range (0.59), whereas severe chronic depression
was valued very close to death (0.04).
Little is known about the valuation of depres-
sion co-occurring with a medical condition, as
most studies so far focused on the valuation of a
somatic condition or of a mental condition, such
as depression. It might be that depression is val-
ued diﬀerently when it co-occurs with a somatic
condition. For example, the impact of depres-
sion on HRQoL might be larger for a person
who copes with cancer than for a somatically
healthy person, as the cancer might negatively
interact and magnify the impact of depression.
The opposite could also be hypothesized, that is
that the impact of depression might be underes-
timated by the cancer patient, who might be
focusing on the impact of cancer and its treat-
ment. Based on the large prevalence of depres-
sion co-occurring with a medical condition, the
potential inﬂuence of somatic conditions on val-
uations of depression needs to be examined and
taken into account when using depression valua-
tions in cost-utility analyses of psychological
interventions oﬀered to somatic patients.
To elicit valuations, diﬀerent methods can be
applied. The time trade-oﬀ (TTO) is considered
a reliable and valid valuation method,11 yet
complex and cognitively demanding.12 In the
majority of valuation studies, diﬃculties related
to the TTO have been reported. Potential diﬃ-
culties related to the feasibility of the TTO pro-
tocol can be subdivided into three levels. First,
some participants might experience major diﬃ-
culties with the task and even fail to complete it
on the whole, or within a reasonable time per-
iod. Second, a number of participants might be
able to complete the task, but assign values in a
pattern that appears logically inconsistent. Some
respondents appear to have diﬃculties discern-
ing between two states, that is assign more
favourable values to the one that is obviously
more severe.13 Third, even participants who are
able to complete the task and assign consistent
values might in fact comprehend or interpret
aspects of the valuation task inappropriately.
For example, an earlier study using the TTO
demonstrates that participants are able to pro-
vide responses even for scenarios they consider
implausible, which implies that they somehow
reinterpret these scenarios.14 Whereas the ﬁrst
ª 2014 John Wiley & Sons Ltd
Health Expectations, 18, pp.3147–3159
Tto-based valuation of co-occurring depression, K Papageorgiou et al.3148
two aspects are usually considered to assess fea-
sibility of TTO protocols, the third aspect has
been given much less attention. In the case of
mental health state valuations, additional chal-
lenges have been reported, for example, regard-
ing discriminative ability,9 and it is reasonable
to assume such challenges to be more profound
when the co-occurring states are concerned.
Our understanding of how co-occurring
depression is valued can further advance by
looking into factors that aﬀect valuations of
depression. For example, individuals might con-
sider that the consequences of depression, for
example ﬁnancial and on the family, are
pronounced when a somatic condition is also
present and thus value co-occurring depression
worse than depression as a solitary state. Up to
now, limited attention has been put on exploring
factors that aﬀect valuations from the perspec-
tive of the individuals. Demographic factors
such as age, gender, marital status15 and experi-
ence with the condition16 have been shown to
aﬀect valuations,17 but evidence is inconsis-
tent.18 Regarding valuations of mental health
states, speciﬁc factors, such as stigma, have been
proposed,10 but have not been studied so
far. With this study, we aimed to gain more
insight into the ways a somatic condition
might potentially aﬀect valuations of depression
and explore other factors that might aﬀect
valuations.
Therefore, we pilot tested TTO-based valua-
tions of depression co-occurring with a somatic
condition. Our ﬁrst aim was to test the feasibil-
ity of the valuation protocol and identify poten-
tial obstacles. Feasibility was based on three
criteria: (i) how many participants are able to
complete the task, how much time is required,
and how participants rate their experienced dif-
ﬁculty and concentration; (ii) to what degree
values are logically consistent; and (iii) how
accurately participants comprehend and inter-
pret the valuation task. The ﬁrst two aspects
were assessed based on a quantitative approach.
We considered the valuation protocol successful
when almost all of the participants were able to
complete the task and rated their experienced
diﬃculty low (mean < 3, on a scale from 0 to
10) and their concentration high (mean > 7, on
a scale from 0 to 10). An in-depth qualitative
approach was employed to examine the compre-
hension and interpretation of the valuation
task. Speciﬁcally, our aim was to make sure that
participants could accurately comprehend the
valuation task according to the instructions pro-
vided and interpret it appropriately. Our second
aim was to explore factors that participants take
into account during their valuations, also based
on a qualitative approach.
Methods
Participants
Participants were volunteers, recruited via
informal networks and were interviewed in the
period of January to March 2011. Invitations
to partake in this study were handed to
employees of the Health Psychology Depart-
ment of the University Medical Center Gronin-
gen with the request to pass it to their
networks outside of the UMCG. In the invita-
tion, information was provided of the general
aim of the study, the interview procedure (i.e.
approximate time required, UMCG setting)
and contact information for the ones interested
to partake. A quota sampling approach was
used to ensure variance with regard to age,
gender and educational background. Inclusion
criteria were the following: age older than
18 years and younger than 70 years, Dutch
nationality, ﬂuency in Dutch or English lan-
guage, and not being professionally involved in
patient health care or research.
As participants were not approached on
behalf of the University Medical Center
Groningen, no approval from the Medical
Ethical Committee was required.
Interview procedure
The interview consisted of three phases. During
the introductory phase, participants provided
background information and learned about the
general aim of the study. Next, the use of
vignettes describing hypothetical health states
ª 2014 John Wiley & Sons Ltd
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was explained. Then, the think aloud method
(TAM) was introduced and practiced on an
irrelevant topic (relationship satisfaction) (more
information on the TAM provided below). In
the main part, participants were introduced to
the TTO task and valued six vignettes describing
depression either as a solitary state (‘Depression
– Solitary’) or co-occurring with a somatic con-
dition (‘Depression – Co-occurring’). In the ﬁnal
part, participants evaluated the tasks and
answered additional questions. Interviews were
performed by two of the authors (KP, FRML)
in a quiet setting and were tape-recorded. Paper
cards with the vignettes, the TTO instructions
and a scale representing life years were used.
Vignettes
Eight vignettes were developed, of which two
described ‘Depression – Solitary’ and six
described ‘Depression – Co-occurring’. The
two ‘Depression – Solitary’ vignettes described
depression health states corresponding to either
a mild or a severe level. These descriptions
were developed based on the McSad depression
speciﬁc utility measure,19 previously validated
in Dutch in patients with somatic conditions.20
The ‘Depression – Co-occurring’ vignettes
described health states of mild depression co-
occurring with cancer, diabetes or heart disease
(three types of somatic conditions), of either
moderate or severe level of dysfunctioning (two
severity levels), resulting in six (2 9 3) diﬀerent
vignettes of ‘Depression – Co-occurring’. These
three speciﬁc types of somatic conditions were
chosen as they commonly co-occur with
depression.21–23 Descriptions of somatic condi-
tions were based on relevant condition-speciﬁc
HRQoL measures.24–26 An example of a vign-
ette describing mild depression co-occurring
with moderate cancer can be found in Table 1.
The two ‘Depression – Solitary’ vignettes were
presented to all participants. Furthermore,
each participant was presented with four of the
‘Depression – Co-occurring’ vignettes, describ-
ing both severity levels for two of the three
somatic conditions. Thus, each participant
valued six vignettes in total.
Measures
Time trade-oﬀ valuation protocol
The TTO task involves asking participants to
imagine living in an adverse health condition
for a certain amount of years (x) and then die
(‘Option A’). Then, participants are asked to
imagine that they could recover from the
adverse state, but this would mean that they
would need to give up a number (y) of their
life years (x) (‘Option B’). For participants
who are willing to trade years (choose Option
B), the number of years to trade (y) varies,
until the maximum is reached (ymax). Based on
their answer, the value for the relevant state is
then calculated as 1  (ymax/x), ranging from 0
(equivalent to death) to 1 (equivalent to perfect
health), with lower values representing worse
valuations.
For the purposes of this study, participants
were asked to imagine living with depression
(‘Depression – Solitary’ or ‘Depression – Co-
occurring’) for the rest of their life, assuming
they will reach the general life expectancy of 80
(http://statline.cbs.nl) (‘Option A’). Then, they
were asked whether they would trade any years
to live in a healthy mental state (‘Option B’).
A ping-pong titration method27 was employed
Table 1 Example of a vignette describing depression (mild)
co-occurring with cancer (moderate)
Imagine that you are a patient with cancer.
• Quite regularly, you have some physical reactions,
especially moderate pain and nausea.
• You also feel tired sometimes.
• You feel somewhat physically restricted and ﬁnd it
relatively diﬃcult to perform your social or family
activities.
In addition to the symptoms of cancer, you experience
symptoms that constitute a diagnosis of depression.
• You feel more down and don’t enjoy things as usual.
• Sometimes, you don’t feel very good about yourself and
see the down-side of everything.
• You have some trouble concentrating and remembering,
and it seems harder to make decisions.
• Things are more of a chore and at times you feel
sluggish or agitated.
• You are able to function okay at work, home, school or
with friends but often don’t enjoy what you are doing or
feel more withdrawn lately.
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to reach the maximum number of years partici-
pants would trade, by means of a scale repre-
senting life years (range from 18 to 80). In the
case of ‘Depression – Co-occurring’ vignettes,
it was made clear that life years would be
traded to live in a healthy mental state, but
with the somatic condition. In that way, we
aimed to assess the burden of depression in the
presence of a somatic condition.
Questionnaires
Prior to the valuations, participants answered
questions regarding their age, occupation,
family status and educational background.
Following the valuations, they reported
experience, either personal or via a close per-
son, with cancer, diabetes, heart disease or
depression; and rated ﬁrst, diﬃculty of under-
standing the task (0: not diﬃcult at all – 10:
very diﬃcult), and second, their concentration
during the task (0: not concentrated at all – 10:
very much concentrated).
Think aloud method
The TAM was used as it is considered the
appropriate method to gain in-depth informa-
tion concerning participants’ comprehension
and interpretation of the valuation task and
factors that aﬀect valuations, which may not
be available otherwise.28,29 During the TTO
tasks, participants were verbalizing all their
thoughts without commenting upon them.30
The interviewer avoided interrupting or
answering questions, but occasionally used
motivational probes to encourage thinking
aloud, for example ‘How did you reach this
answer?’ or ‘What are you thinking now?’
Analysis
The sample was described with regard to their
demographic characteristics. The number of
participants who were able to complete the task
and the time required for six valuations were
considered to assess the ﬁrst feasibility criterion.
Quantitative analyses were used to examine the
second feasibility criterion regarding logical
consistency of values. First, we calculated values
based on the proportion of ymax/x, where ymax
represents the maximum number of years a per-
son was willing to trade and x represents the
total number of years available (80 – age). Then,
we examined whether valuations fulﬁl two fun-
damental hypotheses; ﬁrst, mild depression
should be valued similarly or higher when com-
pared to severe depression; and second, mild
depression should be valued similarly or higher
when it co-occurs with a moderate rather than a
severe state of a somatic condition.
Qualitative analyses of think aloud data were
used to examine the third criterion of feasibility
regarding how appropriately participants com-
prehend and interpret the valuation task, as
well as to answer our second research question
regarding factors that aﬀect valuations. We
used an explicit and systematic three-step qual-
itative analysis, based on the principles of
grounded theory.31 In the ﬁrst step, interview
recordings were transcribed and read several
times, so that frequent or signiﬁcant themes
were extracted in the form of quotes. Quotes
were investigated and grouped into a coding
frame. During the second step, the nine quotes
that were developed in the ﬁrst phase were
compared for similarities or diﬀerences. This
resulted in revising the coding scheme in three
constructs regarding comprehensibility of the
valuation task and one construct regarding fac-
tors that people consider during valuations (six
subconstructs). In the third step, quotes were
recoded to the ﬁnal coding scheme. Interpreta-
tion of the result was based on the ﬁnal coding
scheme. Two of the authors who conducted the
interviews (KP, FRML) also independently
carried out each of those three steps. Initial dif-
ferences were resolved after discussion.
Results
Participants
Participants were ﬁve men and ﬁve women,
aged between 21 and 53 years (mean = 35); all
participants had at least high school education,
and three had postgraduate education; three
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were students, whereas the rest had various
types of paid work; none had personal experi-
ence with any of the health conditions of inter-
est, but all were familiar with at least one of
the conditions via a close person. One extra
interview was ceased before completion because
it was interrupted by a third person, so it is
not included in the analyses.
Feasibility
All 10 participants found the valuation task
acceptable and were able to complete it based
on the standardized instructions. One partici-
pant reported ﬁnding the task unusual, but was
nevertheless able to complete it. One partici-
pant was temporarily confused regarding
the TTO task in the case of ‘Depression –
Co-occurring’, assuming that years would be
traded for curing both depression and the
somatic condition. However, the participant
was able to resolve this confusion soon without
additional explanations. Mean duration for the
six valuation tasks, while thinking aloud was
45 min. Diﬃculty to understand the valuation
task was minimal (mean: 1.9; range: 1–3) and
below the criterion of 3. Concentration was
rated high (mean: 8.3; range: 7–9) and above
the criterion of 7. Therefore, the feasibility cri-
teria were supported by the quantitative data.
Criteria of logical consistency of valuations
were met (see Table 2). On average, but also
per participant, a higher value was attached to
‘Depression – Solitary’ mild (mean: 0.74), com-
pared to severe (mean: 0.36). Furthermore,
on average and per participant, ‘Depression –
Co-occurring’ was valued higher when repre-
senting a moderate rather than a severe level of
the somatic condition. The only exception was
participant 2 who assigned a higher value to
‘Depression – Co-occurring’ when representing
the moderate rather than the severe level (0.56
and 0.49 accordingly), but the diﬀerence was
small and only found in the case of heart
disease.
Based on qualitative analysis of think aloud
data, we identiﬁed three issues related how accu-
rately participants comprehend and interpret
the valuation protocol. Examples quotes are
provided in Table 3.
• Diﬃculty to imagine that one can continue
living with depression for the rest of life.
For ‘Depression – Solitary’ valuations,
participants were instructed to imagine living
with depression for the rest of their life years
(TTO ‘Option A’). However, four partici-
pants mentioned that they could not imagine
that. Instead, they hoped that depression
would become better (participants 2, 4, 8 and
Table 2 Participants’ values per state
Part
Depression – Solitary Depression (mild) co-occurring with
Mild Severe
Cancer Diabetes Heart disease
Moderate Severe Moderate Severe Moderate Severe
1 0.77 0.30 0.77 0.77 0.77 0.77
2 0.91 0.41 0.93 0.65 0.49 0.56
3 0.10 0.00 0.23 0.09 0.18 0.06
4 0.35 0.17 0.26 0.17 0.45 0.08
5 0.75 0.54 0.75 0.75 0.83 0.66
6 0.75 0.58 0.83 0.58 0.83 0.58
7 0.91 0.64 0.86 0.78 0.87 0.82
8 0.82 0.27 0.46 0.36 0.41 0.13
9 1.00 0.26 0.37 0.30 1.00 0.74
10 1.00 0.43 1.00 0.20 0.43 0.43
Mean 0.74 0.36 0.65 0.45 0.63 0.47 0.63 0.59
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10). Two participants (participants 9 and 10)
assumed that if they were to live with depres-
sion, they might commit suicide.
• Diﬃculty to imagine that one who lives with
depression and cancer/diabetes/heart disease
will reach the age of 80.
For the valuation of ‘Depression – Co-
occurring’, participants were asked to imag-
ine living with depression and the somatic
condition for the rest of their life, expected
to be 80 years (TTO ‘Option A’). Six partic-
ipants reported the life expectancy was unre-
alistically high (participants 1, 4, 5, 7, 9 and
10). For ‘Depression – Solitary’, this was
the case for one participant (participant 8).
• Diﬃculty to imagine that one who lives with
cancer/diabetes/heart disease can be mentally
healthy.
For ‘Depression – Co-occurring’, partici-
pants were asked about life years they
would be willing to trade to live in a healthy
mental state, but with the somatic condition
(TTO ‘Option B’). However, three partici-
pants mentioned that they expected to feel
depressed when they would have a somatic
disease (participants 5, 6 and 10). Moreover,
three others mentioned that they cannot see
the beneﬁts of trading years to cure depres-
sion, as it is not possible for someone who
experiences the somatic condition not to be
depressed (participants 4, 8 and 9).
Factors that affect valuations
During thinking aloud, participants explicitly
referred to certain factors that they took into
account while completing the TTO task. Exam-
ples quotes are provided in Table 3.
State-related factor
• Compare the burden of the depression to the
burden of the somatic condition
To value ‘Depression – Co-occurring’ states,
participants were asked to reach their
TTO decisions by comparing living with
depression and a somatic condition to living
in a healthy mental state and a somatic con-
dition. However, some participants seemed
to change their comparison standards and
compared depression to the somatic condi-
tions (and not to its absence, as implied by
the task) (participants 3, 4, 7, 8 and 9). This
usually resulted in more hesitancy to trade
years for depression, when depression was
considered less bad a condition than the
somatic condition.
Person-related factors
While completing the TTO tasks, participants
referred to the following factors. Example
quotes can be found in Table 3.
• Experience with the condition(s)
Nine of the participants referred to their
experiences, either personal or via a close
person, with the depression or the somatic
condition (participants 1, 2, 3, 4, 5, 6, 7, 9
and 10).
• Signiﬁcant others
Half of the participants (participants 4, 5, 6,
8 and 9) referred to their family members.
Consideration of signiﬁcant others for some
encouraged, whereas for others discouraged
the trade-oﬀ of life years.
• Religion
Two participants (participants 5 and 9)
referred to their religious beliefs. In one
case, religion was related to reluctance to
trade years, while the opposite held for the
other case.
• Perceived susceptibility
Four participants referred to their estimated
possibility of themselves actually experienc-
ing depression. Three participants mentioned
that they consider themselves not susceptible
for depression (participants 2, 5, 9 and 10),
while one of them (participant 10) reported
that everyone can be susceptible to cancer,
in contrast to depression.
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• Age of retirement
Two participants (participants 5 and 7) con-
sidered retirement age.
Discussion
Our ﬁrst aim was to examine the feasibility of
a TTO-based protocol to elicit valuations of
depression, as either a solitary state or co-
occurring with a somatic condition. Overall,
our quantitative data suggest that the criteria
concerning the completion rate, time required,
self-reports of task diﬃculty and concentration,
and logical consistency of valuations have been
met, and thus, feasibility of the valuation pro-
tocol is supported. Nevertheless, our qualitative
data did indicate that certain aspects of the
protocol impose challenges related to the com-
prehension and the interpretation of the valua-
tion task. First, some participants found it
diﬃcult to imagine living until 80 years old as
suggested by the TTO. Such a contrast between
subjective life expectancy and the life expec-
tancy as described in the TTO health states
has been previously reported.32,33 Furthermore,
Table 3 Qualitative analysis example quotes
Comprehension/interpretation of the valuation protocol
Difﬁculty to imagine that one can continue living with depression for the rest of life
• ‘then I will always hope that in the years to come I will heal myself’
• ‘If I wouldn’t take that medicine, I would probably kill myself’
Part 2
Part 9
Difﬁculty to imagine that one who lives with depression and cancer/diabetes/
heart disease will reach the age of 80
• ‘I think I would be dead anyway within 10 years’
• ‘I think I will never be 80 with this, because I don’t have an interest in food’
Part 9
Part 8
Difﬁculty to imagine that one who lives with cancer/diabetes/heart disease can be mentally healthy
• ‘I think that the physical symptoms will make you depressed anyway’
• ‘I can’t see the positive thing that depression will take away, because I think I’ll also feel depressed
because I can’t do anything’
Part 6
Part 8
Factors that affect valuations
Compare the burden of the depression to the burden of the somatic condition
• ‘Depression feels more diﬃcult to handle than the diabetes’
• ‘the bottom symptoms (i.e. depression) really disappear for me compared to the top ones (i.e. cancer)’
Part 8
Part 7
Experience with the condition(s)
• ‘I felt a little bit depressed last year’




• ‘I don’t want to do that to my family, that they have to see so long that I’m full of pain and
can’t do anything with them’




• ‘I am raised like Calvinist and that means that the things that burden you, you have to face it and go on. . .’




• ‘I am a very active coping person, depression doesn’t belong to me’




• ‘65 is the age which you stop working in Holland’
• ‘you still have been able to enjoy being retired’
Part 5
Part 7
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some participants faced diﬃculties in imagining
that they would be depressed for the rest of
their life. Diﬃculties were also encountered
with imagining living with a somatic condition
and at the same time being mentally healthy
and not depressed. We also identiﬁed several
factors that may aﬀect valuations of depres-
sion, including personal experience with the
health condition, perceived susceptibility to the
health state and considerations of the impact
of the health state of signiﬁcant others.
This was the ﬁrst in-depth study of the feasi-
bility of using the TTO task in valuations of
depression in the case of depression co-
occurring with a somatic condition. The results
showed that, when testing the feasibility of the
valuation task, it is crucial to examine both
task completion and accuracy of comprehen-
sion and interpretation. So far, only few stud-
ies have examined how participants actually
interpret the valuation task.34 In the case of
depression, no in-depth study of the TTO feasi-
bility has been performed, although challenges
have been reported.9 One key ﬁnding of the
current study is that participants tend to misin-
terpret certain aspects of the valuation protocol
(e.g. imagine living with a somatic condition
but mentally healthy), when these aspects are
in contrast to their own subjective beliefs (e.g.
beliefs that one who is somatically ill cannot
be free of depression). By identifying such chal-
lenges, we took an important ﬁrst step towards
improving the feasibility of our protocol and
enhancing the validity of valuation outcomes.
The extent to which such challenges inﬂuence
valuations of depression or other mental states
should be further explored. Furthermore, with
this study, we examined the TTO protocol
when valuing one health state in the presence
of a co-occurring diﬀerent state. This has been
rarely reported in previous literature,35,36 as the
majority of studies on co-occurring health
states have focused on predicting values for
joint health states from single health states.37,38
In the light of our ﬁndings, certain aspects
of the TTO valuation protocol can be read-
dressed. Concerning the TTO time frame, we
used a general life expectancy time frame,
previously used in TTO protocols for depres-
sion39 and other mental40,41 and somatic condi-
tions.32,42,43 One could argue that for some
participants, reaching an age 80 might be a
very short life expectancy; for others, it may be
long, also based upon age when providing the
valuation. Yet valuations are computed based
on the percentage of the years traded out of
the total life years and the time frame is subject
to choice. The 80 years life expectancy time
frame appeared acceptable for solitary depres-
sion, but imposed challenges for co-occurring
depression, for which the also commonly used
time frame of 10 years’ time frame might be
more appropriate.44 Undoubtedly, the choice
of a time frame appropriate for depression
both as a solitary and as a co-occurring state is
a challenging one. Diﬃculty to imagine that
depression will remain for the rest of the life
could be explained given the episodic nature of
depression and subjective perceptions regarding
the nature and course of depression. One
approach could be to inform participants that
during lifetime, depressive episodes will alter-
nate with periods of remission. Diﬃculty to
imagine living with a somatic condition but
remaining mentally healthy could be explained
by lay perceptions that a somatic condition
automatically induces depression. This could
be partly addressed by providing participants
with some background information that it is
only a minority of chronic somatic patients
who actually experience depression.1 Such
information might also be appropriate when
valuing other conditions often met co-
occurring, for example obesity and diabetes.
The clinical implications of the assessment and
subsequent reﬁnement of the valuation proto-
col for co-occurring depression, as proposed by
this study, are also worth discussing. By ensur-
ing that valuations of depression, either co-
occurring or solitary, can be elicited using the
same method (i.e. the TTO), as suggested by
the current study, the next step is to examine
how a somatic condition might aﬀect how the
impact of depression is perceived. By taking
this potential eﬀect into account, we can more
validly assess the eﬀectiveness of psychological
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interventions when oﬀered to somatically
healthy or unhealthy individuals, and even
comprehend possible diﬀerences.
As a ﬁrst attempt to explore factors that
aﬀect valuation of – co-occurring – depression,
the think aloud method proved to be of great
value. In the case of ‘Depression – Co-
occurring’ vignettes, participants were asked to
imagine living with depression and a somatic
condition and then trade years to live without
depression but with the somatic condition. In
other words, participants had to value co-
occurring depression by comparing the pres-
ence of depression to its absence, always in
the presence of a somatic condition. Yet, it
seemed that, despite TTO instructions, some
adopted another strategy to value co-occurring
depression. Speciﬁcally, to value co-occurring
depression, some participants compared it to
the somatic condition (e.g. ‘depression feels
more diﬃcult to handle than the diabetes’).
This ﬁnding implies that the impact of depres-
sion might be underestimated when the focus
is turned to the somatic condition. Our study
adds to previous ﬁndings regarding the possi-
ble role of religion and beliefs about life45,46
and marital status,15 by highlighting the
important role of signiﬁcant others, that is,
how living with depression and/or deciding to
trade years would aﬀect one’s children and
partners. In addition to previous results con-
cerning eﬀect of personal experience on
valuations,47,48 we pointed out the role of
experience via other persons and that of per-
ceived susceptibility for depression on valua-
tions of depression, which have not been
previously studied. The identiﬁcation of such
factors that may inﬂuence valuations allows us
to gain more insight into the reasons why
depression might be perceived as more or less
burdensome by diﬀerent individuals, which
appears valuable also from a clinical perspec-
tive. For example, our ﬁnding that how bur-
densome individuals with somatic condition
perceive depression depends, among others, on
how they compare it to the somatic condition
should possibly be taken into account in
designing eﬀective psychological interventions.
Certain limitations of the study need to be
discussed. Given the pilot purpose and the
speciﬁcity of the research questions, our sample
size was limited to 10 interviews. Although we
aimed at its representativeness with regard to
gender, age and educational background, the
limited sample size allows only for strictly
exploratory interpretations of quantitative
data. For the qualitative analysis, though, we
did estimate the saturation level within this
sample as satisfactory. Concerning descriptions
of the somatic conditions, these were based on
reviews and existing measures and participants
reported no diﬃculties. However, inclusion of
patients or clinicians in their development and
psychometric testing is necessary to establish
their representativeness. Besides, given the lim-
ited number of participants and limited number
of states that they could be asked to value, we
decided to focus on two depressive states vary-
ing in severity, as well as only mild depression
state co-occurring with a medical condition
varying in severity. More combinations are pos-
sible and interesting, for instance, also severe
depression states with the two types of severe
medical conditions. However, we decided this to
not be feasible for the current study; otherwise,
interviews would have become too long for
participants.
Finally, TTO-related biases,46,49,50 not
related to task comprehension, such as loss
aversion and scale compatibility, were not con-
sidered when analysing think aloud data.
Overall, use of both quantitative and qualita-
tive data to examine the valuation protocol
proved useful to identify validity threats and to
understand underlying mechanisms and can be
suggested for valuation research. The extent to
which our ﬁndings can be generalized to other
conditions (e.g. somatic conditions) and popu-
lations (e.g. patients) remains to be explored.
Conclusions
As a ﬁrst step towards valuations of depression
co-occurring with a somatic condition, we
tested the feasibility of a TTO-based valuation
protocol. Quantitative ﬁndings supported
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feasibility, although potential challenges were
identiﬁed, by means of qualitative data. Fac-
tors that seem to aﬀect valuations were identi-
ﬁed, for example, perceived susceptibility to
depression and considerations of signiﬁcant
others. Therefore, we suggest certain adjust-
ments in the valuation protocol and further
investigation of currently unexplored factors.
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